Deepa Dahal is Co-founder and Executive Partner at DKI Health, a global strategic consultancy integrating clinical, commercial, and public health expertise with patient needs to address modern challenges in healthcare. She leads a global team of professionals who share a vision to “create a world where good health is possible, accessible, and equitable,"and finds her joy in doing meaningful work such as innovating in healthcare through true patient-centricity. Her therapeutic areas of expertise include oncology, immunology, neurology, infectious disease, and rare diseases. A recognized leader in her field, she has been widely published on various topics, including patient and caregiver perspectives, biosimilars, anti-microbial resistance, and COVID-19. Before co-founding DKI Health, Deepa held senior consulting positions at Campbell Alliance (now Syneos) and IQVIA. She completed her undergraduate degree at the University of Idaho and earned an MBA from the University of New Hampshire.